Loading clinical trials...
Loading clinical trials...
Randomized Trial of Epoetin Alfa in Patients With Advanced Non-Small Cell Carcinoma of the Lung (EPO-CAN-20)
Conditions
Interventions
Epoetin Alfa
Locations
15
Canada
Tom Baker Cancer Centre
Calgary, Alberta, Canada
Cross Cancer Institute
Edmonton, Alberta, Canada
Cancer Care Manitoba
Winnipeg, Manitoba, Canada
St. John Regional Hospital
Saint John, New Brunswick, Canada
Newfoundland Cancer Treatment & Research Foundation
St. John's, Newfoundland and Labrador, Canada
Nova Scotia Cancer Centre
Halifax, Nova Scotia, Canada
Start Date
February 1, 2001
Completion Date
April 1, 2004
Last Updated
April 2, 2024
NCT06043817
NCT05671510
NCT07177937
NCT03050268
NCT06426511
NCT06498635
Lead Sponsor
Ontario Clinical Oncology Group (OCOG)
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions